Taiyen Biotech Co., Ltd. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was TWD 813.3 million compared to TWD 865 million a year ago. Net income was TWD 104.39 million compared to TWD 108.13 million a year ago.

Basic earnings per share from continuing operations was TWD 0.52 compared to TWD 0.54 a year ago. Diluted earnings per share from continuing operations was TWD 0.52 compared to TWD 0.54 a year ago.